These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Exertional hypoxemia in stable COPD is common and predicted by circulating proadrenomedullin. Stolz D; Boersma W; Blasi F; Louis R; Milenkovic B; Kostikas K; Aerts JG; Rohde G; Lacoma A; Rakic J; Boeck L; Castellotti P; Scherr A; Marin A; Hertel S; Giersdorf S; Torres A; Welte T; Tamm M Chest; 2014 Aug; 146(2):328-338. PubMed ID: 24722847 [TBL] [Abstract][Full Text] [Related]
5. Impact of adherence to long-term oxygen therapy on patients with COPD and exertional hypoxemia followed for one year. Mesquita CB; Knaut C; Caram LMO; Ferrari R; Bazan SGZ; Godoy I; Tanni SE J Bras Pneumol; 2018; 44(5):390-397. PubMed ID: 30517340 [TBL] [Abstract][Full Text] [Related]
6. The Use of Pulse Oximetry to Determine Hypoxemia in Acute Exacerbations of COPD. Garcia-Gutierrez S; Unzurrunzaga A; Arostegui I; Quintana JM; Pulido E; Gallardo MS; Esteban C; COPD; 2015; 12(6):613-20. PubMed ID: 25774875 [TBL] [Abstract][Full Text] [Related]
8. Defining the role of exertional hypoxemia and pulmonary vasoconstriction on lung function decline, morbidity, and mortality in patients with chronic obstructive lung disease - the PROSA study: rationale and study design. Böger R; Hannemann J BMC Pulm Med; 2024 May; 24(1):262. PubMed ID: 38816826 [TBL] [Abstract][Full Text] [Related]
9. Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts. Fawzy A; Putcha N; Paulin LM; Aaron CP; Labaki WW; Han MK; Wise RA; Kanner RE; Bowler RP; Barr RG; Hansel NN; Respir Res; 2018 Jan; 19(1):20. PubMed ID: 29373977 [TBL] [Abstract][Full Text] [Related]
10. Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease. Stoller JK; Aboussouan LS; Kanner RE; Wilson LA; Diaz P; Wise R; Ann Am Thorac Soc; 2015 Dec; 12(12):1796-804. PubMed ID: 26653189 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary Artery Enlargement Is Associated With Cardiac Injury During Severe Exacerbations of COPD. Wells JM; Morrison JB; Bhatt SP; Nath H; Dransfield MT Chest; 2016 May; 149(5):1197-204. PubMed ID: 26501747 [TBL] [Abstract][Full Text] [Related]
12. Short-term Effects of Supplemental Oxygen on 6-Min Walk Test Outcomes in Patients With COPD: A Randomized, Placebo-Controlled, Single-blind, Crossover Trial. Jarosch I; Gloeckl R; Damm E; Schwedhelm AL; Buhrow D; Jerrentrup A; Spruit MA; Kenn K Chest; 2017 Apr; 151(4):795-803. PubMed ID: 27940278 [TBL] [Abstract][Full Text] [Related]
13. Predictors for PaO2 and hypoxemic respiratory failure in COPD-A three-year follow-up. Saure EW; Eagan TM; Jensen RL; Bakke PS; Johannessen A; Aanerud M; Nilsen RM; Thorsen E; Hardie JA COPD; 2014 Sep; 11(5):531-8. PubMed ID: 24831555 [TBL] [Abstract][Full Text] [Related]
14. β-Blockers are associated with a reduction in COPD exacerbations. Bhatt SP; Wells JM; Kinney GL; Washko GR; Budoff M; Kim YI; Bailey WC; Nath H; Hokanson JE; Silverman EK; Crapo J; Dransfield MT; Thorax; 2016 Jan; 71(1):8-14. PubMed ID: 26283710 [TBL] [Abstract][Full Text] [Related]
15. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD. Fan VS; Ramsey SD; Make BJ; Martinez FJ COPD; 2007 Mar; 4(1):29-39. PubMed ID: 17364675 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for developing hypoxic respiratory failure in COPD. Sundh J; Ekström M Int J Chron Obstruct Pulmon Dis; 2017; 12():2095-2100. PubMed ID: 28790812 [TBL] [Abstract][Full Text] [Related]
17. Oxygen desaturation in 6-min walk test is a risk factor for adverse outcomes in COPD. Waatevik M; Johannessen A; Gomez Real F; Aanerud M; Hardie JA; Bakke PS; Lind Eagan TM Eur Respir J; 2016 Jul; 48(1):82-91. PubMed ID: 27076586 [TBL] [Abstract][Full Text] [Related]
18. Long-Term Oxygen Therapy in COPD Patients Who Do Not Meet the Actual Recommendations. Ergan B; Nava S COPD; 2017 Jun; 14(3):351-366. PubMed ID: 28506089 [TBL] [Abstract][Full Text] [Related]
19. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease. Faganello MM; Tanni SE; Sanchez FF; Pelegrino NR; Lucheta PA; Godoy I Am J Med Sci; 2010 Jan; 339(1):10-4. PubMed ID: 19926966 [TBL] [Abstract][Full Text] [Related]
20. Relationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohort. DiSantostefano RL; Hinds D; Le HV; Barnes NC Respir Med; 2016 Mar; 112():88-96. PubMed ID: 26872700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]